ID   Q5F4T5_9CALI            Unreviewed;       548 AA.
AC   Q5F4T5;
DT   15-MAR-2005, integrated into UniProtKB/TrEMBL.
DT   15-MAR-2005, sequence version 1.
DT   03-AUG-2022, entry version 71.
DE   SubName: Full=Capsid protein {ECO:0000313|EMBL:AAT12445.1};
OS   Norwalk virus.
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Picornavirales; Caliciviridae; Norovirus.
OX   NCBI_TaxID=11983 {ECO:0000313|EMBL:AAT12445.1, ECO:0000313|Proteomes:UP000157806};
RN   [1] {ECO:0000313|EMBL:AAT12445.1, ECO:0000313|Proteomes:UP000157806}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Vietnam 026 {ECO:0000313|EMBL:AAT12445.1};
RX   PubMed=15593412; DOI=10.1007/s00705-004-0345-4;
RA   Hansman G.S., Doan L.T., Kguyen T.A., Okitsu S., Katayama K., Ogawa S.,
RA   Natori K., Takeda N., Kato Y., Nishio O., Noda M., Ushijima H.;
RT   "Detection of norovirus and sapovirus infection among children with
RT   gastroenteritis in Ho Chi Minh City, Vietnam.";
RL   Arch. Virol. 149:1673-1688(2004).
RN   [2] {ECO:0007829|PDB:3ONU, ECO:0007829|PDB:3ONY}
RP   X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 224-538 IN COMPLEX WITH FUCOSE;
RP   GALACTOSE AND N-ACETYL-D-GLUCOSAMINE.
RX   PubMed=21525337; DOI=10.1128/JVI.00246-11;
RA   Hansman G.S., Biertumpfel C., Georgiev I., McLellan J.S., Chen L., Zhou T.,
RA   Katayama K., Kwong P.D.;
RT   "Crystal structures of GII.10 and GII.12 norovirus protruding domains in
RT   complex with histo-blood group antigens reveal details for a potential site
RT   of vulnerability.";
RL   J. Virol. 85:6687-6701(2011).
RN   [3] {ECO:0007829|PDB:3RY8}
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 225-538.
RX   PubMed=22031945; DOI=10.1128/JVI.05909-11;
RA   Hansman G.S., Shahzad-Ul-Hussan S., McLellan J.S., Chuang G.Y.,
RA   Georgiev I., Shimoike T., Katayama K., Bewley C.A., Kwong P.D.;
RT   "Structural basis for norovirus inhibition and fucose mimicry by citrate.";
RL   J. Virol. 86:284-292(2012).
RN   [4] {ECO:0007829|PDB:3V7A}
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 224-538.
RX   PubMed=22278249; DOI=10.1128/JVI.06868-11;
RA   Hansman G.S., Taylor D.W., McLellan J.S., Smith T.J., Georgiev I.,
RA   Tame J.R., Park S.Y., Yamazaki M., Gondaira F., Miki M., Katayama K.,
RA   Murata K., Kwong P.D.;
RT   "Structural basis for broad detection of genogroup II noroviruses by a
RT   monoclonal antibody that binds to a site occluded in the viral particle.";
RL   J. Virol. 86:3635-3646(2012).
RN   [5] {ECO:0007829|PDB:4X7E, ECO:0007829|PDB:4X7F}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 224-538.
RX   PubMed=25520510; DOI=10.1128/JVI.03176-14;
RA   Koromyslova A.D., Hansman G.S.;
RT   "Nanobody binding to a conserved epitope promotes norovirus particle
RT   disassembly.";
RL   J. Virol. 89:2718-2730(2015).
RN   [6] {ECO:0007829|PDB:4Z4R, ECO:0007829|PDB:4Z4S}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 224-538 IN COMPLEX WITH FUCOSE.
RX   PubMed=25980740; DOI=10.1016/j.virol.2015.04.006;
RA   Koromyslova A.D., Leuthold M.M., Bowler M.W., Hansman G.S.;
RT   "The sweet quartet: Binding of fucose to the norovirus capsid.";
RL   Virology 483:203-208(2015).
RN   [7] {ECO:0007829|PDB:5BSX, ECO:0007829|PDB:5BSY}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 224-538.
RX   PubMed=26295280; DOI=10.1016/j.virol.2015.07.009;
RA   Koromyslova A.D., White P.A., Hansman G.S.;
RT   "Treatment of norovirus particles with citrate.";
RL   Virology 485:199-204(2015).
RN   [8] {ECO:0007829|PDB:5HZA, ECO:0007829|PDB:5HZB}
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 224-538 IN COMPLEX WITH FUCOSE
RP   AND GLUCOSE.
RX   PubMed=26889023; DOI=10.1128/JVI.03223-15;
RA   Weichert S., Koromyslova A., Singh B.K., Hansman S., Jennewein S.,
RA   Schroten H., Hansman G.S.;
RT   "Structural Basis for Norovirus Inhibition by Human Milk
RT   Oligosaccharides.";
RL   J. Virol. 90:4843-4848(2016).
RN   [9] {ECO:0007829|PDB:5O03, ECO:0007829|PDB:5O04}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 224-538.
RX   PubMed=29095961; DOI=10.1371/journal.ppat.1006636;
RA   Koromyslova A.D., Hansman G.S.;
RT   "Nanobodies targeting norovirus capsid reveal functional epitopes and
RT   potential mechanisms of neutralization.";
RL   PLoS Pathog. 13:e1006636-e1006636(2017).
RN   [10] {ECO:0007829|PDB:6GY9}
RP   X-RAY CRYSTALLOGRAPHY (1.83 ANGSTROMS) OF 225-538.
RX   PubMed=30071731; DOI=10.1021/acs.biomac.8b00829;
RA   Bucher K.S., Yan H., Creutznacher R., Ruoff K., Mallagaray A.,
RA   Grafmuller A., Dirks J.S., Kilic T., Weickert S., Rubailo A., Drescher M.,
RA   Schmidt S., Hansman G., Peters T., Uetrecht C., Hartmann L.;
RT   "Fucose-Functionalized Precision Glycomacromolecules Targeting Human
RT   Norovirus Capsid Protein.";
RL   Biomacromolecules 19:3714-3724(2018).
RN   [11] {ECO:0007829|PDB:6GW1, ECO:0007829|PDB:6GW2}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 225-538.
RX   PubMed=30355683; DOI=10.1128/JVI.01581-18;
RA   Kilic T., Koromyslova A., Hansman G.S.;
RT   "Structural Basis for Human Norovirus Capsid Binding to Bile Acids.";
RL   J. Virol. 93:0-0(2018).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF504671; AAT12445.1; -; Genomic_RNA.
DR   PDB; 3ONU; X-ray; 1.40 A; A/B=225-538.
DR   PDB; 3ONY; X-ray; 1.85 A; A/B/C=225-538.
DR   PDB; 3PA1; X-ray; 1.48 A; A/B=224-538.
DR   PDB; 3PA2; X-ray; 1.48 A; A/B=224-538.
DR   PDB; 3Q38; X-ray; 1.28 A; A/B=224-538.
DR   PDB; 3Q39; X-ray; 1.25 A; A/B=224-538.
DR   PDB; 3Q3A; X-ray; 1.40 A; A/B=224-538.
DR   PDB; 3Q6Q; X-ray; 1.43 A; A/B=224-538.
DR   PDB; 3Q6R; X-ray; 1.40 A; A/B=224-538.
DR   PDB; 3RY8; X-ray; 1.40 A; A/B=225-538.
DR   PDB; 3V7A; X-ray; 3.30 A; A/B=224-538.
DR   PDB; 4X7E; X-ray; 2.11 A; A/B=224-538.
DR   PDB; 4X7F; X-ray; 1.70 A; A/B=224-538.
DR   PDB; 4Z4R; X-ray; 1.80 A; A/B=224-538.
DR   PDB; 4Z4S; X-ray; 1.80 A; A/B=224-538.
DR   PDB; 4Z4T; X-ray; 1.80 A; A/B=224-538.
DR   PDB; 4Z4U; X-ray; 1.89 A; A/B=224-538.
DR   PDB; 4Z4V; X-ray; 1.80 A; A/B=224-538.
DR   PDB; 4Z4W; X-ray; 1.80 A; A/B=224-538.
DR   PDB; 4Z4Y; X-ray; 1.80 A; A/B=224-538.
DR   PDB; 4Z4Z; X-ray; 1.80 A; A/B=224-538.
DR   PDB; 5BSX; X-ray; 1.78 A; A/B=224-538.
DR   PDB; 5BSY; X-ray; 1.60 A; A/B=224-538.
DR   PDB; 5HZA; X-ray; 1.35 A; A/B=224-538.
DR   PDB; 5HZB; X-ray; 1.55 A; A/B=224-538.
DR   PDB; 5O03; X-ray; 2.19 A; A/B=224-538.
DR   PDB; 5O04; X-ray; 2.30 A; A/B=224-538.
DR   PDB; 5O05; X-ray; 2.00 A; A/B=224-538.
DR   PDB; 5OMM; X-ray; 1.70 A; A/B=224-538.
DR   PDB; 5OMN; X-ray; 2.68 A; B=224-538.
DR   PDB; 6GW1; X-ray; 1.90 A; A/B=225-538.
DR   PDB; 6GW2; X-ray; 2.05 A; A/B=225-538.
DR   PDB; 6GY9; X-ray; 1.83 A; A/B=225-538.
DR   PDBsum; 3ONU; -.
DR   PDBsum; 3ONY; -.
DR   PDBsum; 3PA1; -.
DR   PDBsum; 3PA2; -.
DR   PDBsum; 3Q38; -.
DR   PDBsum; 3Q39; -.
DR   PDBsum; 3Q3A; -.
DR   PDBsum; 3Q6Q; -.
DR   PDBsum; 3Q6R; -.
DR   PDBsum; 3RY8; -.
DR   PDBsum; 3V7A; -.
DR   PDBsum; 4X7E; -.
DR   PDBsum; 4X7F; -.
DR   PDBsum; 4Z4R; -.
DR   PDBsum; 4Z4S; -.
DR   PDBsum; 4Z4T; -.
DR   PDBsum; 4Z4U; -.
DR   PDBsum; 4Z4V; -.
DR   PDBsum; 4Z4W; -.
DR   PDBsum; 4Z4Y; -.
DR   PDBsum; 4Z4Z; -.
DR   PDBsum; 5BSX; -.
DR   PDBsum; 5BSY; -.
DR   PDBsum; 5HZA; -.
DR   PDBsum; 5HZB; -.
DR   PDBsum; 5O03; -.
DR   PDBsum; 5O04; -.
DR   PDBsum; 5O05; -.
DR   PDBsum; 5OMM; -.
DR   PDBsum; 5OMN; -.
DR   PDBsum; 6GW1; -.
DR   PDBsum; 6GW2; -.
DR   PDBsum; 6GY9; -.
DR   SMR; Q5F4T5; -.
DR   UniLectin; Q5F4T5; -.
DR   ABCD; Q5F4T5; 10 sequenced antibodies.
DR   EvolutionaryTrace; Q5F4T5; -.
DR   Proteomes; UP000157806; Genome.
DR   CDD; cd00205; rhv_like; 1.
DR   Gene3D; 2.60.120.20; -; 1.
DR   InterPro; IPR004005; Calicivirus_coat.
DR   InterPro; IPR013643; Calicivirus_coat_C.
DR   InterPro; IPR033703; Rhv-like.
DR   InterPro; IPR029053; Viral_coat.
DR   Pfam; PF00915; Calici_coat; 1.
DR   Pfam; PF08435; Calici_coat_C; 1.
PE   1: Evidence at protein level;
KW   3D-structure {ECO:0007829|PDB:3ONU, ECO:0007829|PDB:3ONY}.
FT   DOMAIN          12..275
FT                   /note="Calici_coat"
FT                   /evidence="ECO:0000259|Pfam:PF00915"
FT   DOMAIN          307..546
FT                   /note="Calici_coat_C"
FT                   /evidence="ECO:0000259|Pfam:PF08435"
FT   BINDING         299
FT                   /ligand="Galactose"
FT                   /ligand_id="ChEBI:CHEBI:27667"
FT                   /evidence="ECO:0007829|PDB:3Q3A"
FT   BINDING         355
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:3ONY, ECO:0007829|PDB:3PA1"
FT   BINDING         356
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:3ONY, ECO:0007829|PDB:3PA1"
FT   BINDING         381
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:3PA2"
FT   BINDING         382
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0007829|PDB:3Q3A"
FT   BINDING         385
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:3ONY, ECO:0007829|PDB:3PA1"
FT   BINDING         400
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0007829|PDB:3PA2"
FT   BINDING         401
FT                   /ligand="Glucose"
FT                   /ligand_id="ChEBI:CHEBI:17925"
FT                   /evidence="ECO:0007829|PDB:5HZB"
FT   BINDING         401
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0007829|PDB:3PA2"
FT   BINDING         449
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0007829|PDB:3Q3A"
FT   BINDING         451
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:3ONY, ECO:0007829|PDB:3PA1"
FT   BINDING         451
FT                   /ligand="Galactose"
FT                   /ligand_id="ChEBI:CHEBI:27667"
FT                   /evidence="ECO:0007829|PDB:3Q39"
FT   BINDING         452
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:3ONY, ECO:0007829|PDB:3PA2"
FT   BINDING         530
FT                   /ligand="Galactose"
FT                   /ligand_id="ChEBI:CHEBI:27667"
FT                   /evidence="ECO:0007829|PDB:5HZA"
FT   BINDING         532
FT                   /ligand="Fucose"
FT                   /ligand_id="ChEBI:CHEBI:42548"
FT                   /evidence="ECO:0007829|PDB:5HZB"
FT   BINDING         532
FT                   /ligand="Galactose"
FT                   /ligand_id="ChEBI:CHEBI:27667"
FT                   /evidence="ECO:0007829|PDB:3PA1, ECO:0007829|PDB:3Q39"
FT   BINDING         532
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0007829|PDB:3PA2"
FT   BINDING         534
FT                   /ligand="Galactose"
FT                   /ligand_id="ChEBI:CHEBI:27667"
FT                   /evidence="ECO:0007829|PDB:3PA2, ECO:0007829|PDB:3Q39"
SQ   SEQUENCE   548 AA;  59900 MW;  FDB134B87D09A39B CRC64;
     MKMASNDAAP SNDGAAGLVP ESNNEVMALE PVAGASLAAP VTGQTNIIDP WIRMNFVQAP
     NGEFTVSPRN SPGEVLLNLE LGPELNPYLA HLSRMYNGYA GGMEVQIMLA GNAFTAGKLI
     FAAVPPHFPI ENLSPPQITM FPHVIIDVRT LEPVLLPMPD IRNSFFHFIQ RDEPKMRLVA
     MLYTPLRSNG SGDDVFTVSC RVLTRPTPDF DFTYLVPPTV ESKSKPFTLP ILTLGELTNS
     RFPLPIDVLY TNPNESAIVQ CQNGRCTLDG ELQGTTQLLP TGICAFRGKV TQQVQDEHRG
     THWNMTVTNL NGTPFDPTED VPAPLGTPDF SGQIYGVISQ RNTNTVPGEG NLPANRAHEA
     VIATYSPKFT PKLGNIQFST WETQDVSSGQ PTKFTPVGLA SVDANSHFDQ WTLPSYSGAL
     TLNMNLAPSV APVFPGECLL FFRSFIPLKG GYGNPAIDCL MPQEWVQHLY QESAPSLSDV
     ALVRYVNPET GRTLFEAKLH RNGFLTVARN SAGPVVAPTN GYFRFDSWVN QFYTLAPMGN
     GSGRRRMQ
//
